Altis Biosystems, Inc. — Form D/A
Altis Biosystems, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2020-07-22. The offering totals $3.1M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-22
- Form: D/A
- Accession: 0001799892-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.1M
- Amount sold: $3.1M
- Investors: 42
- Date of first sale: 2019-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-358465
Issuer
- Name: Altis Biosystems, Inc.
- CIK: 0001799892
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6 DAVIS DRIVE, DURHAM, NC, 27709
- Phone: 516-255-7290
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| CHRISTOPHER PERKINS | Director | New York, NY |
| Christopher Sims | Director | St. Louis, MO |
| Christopher Sims | Executive Officer | St. Louis, MO |
| Michael Dial | Director | Durham, NC |
| Benjamin Scruggs | Director | Durham, NC |
| Benjamin Scruggs | Executive Officer | Durham, NC |
| Jimmy Smedley | Executive Officer | Durham, NC |
| Susan Mahony | Director | Durham, NC |
| Kevin Causey | Director | Durham, NC |
| Joseph McMahon | Director | Durham, NC |
| Samuel Franklin | Director | Durham, NC |
| Michael Biron | Director | Durham, NC |
| Michael Biron | Executive Officer | Durham, NC |
Other filings by this issuer (3)
More